Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Lucy Therapeutics, Inc. See All Filings	D/A	2024-05-02 10:23:17 UTC
Amount To Be Raised $10,552,797 Associated Brokers / Dealers N/A CIK Number 0001782250 Filed Document 0001782250-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-05-02 10:23:17 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Lucy Therapeutics, Inc. See All Filings	D	2023-12-22 20:46:14 UTC
Amount To Be Raised $9,000,000 Associated Brokers / Dealers N/A CIK Number 0001782250 Filed Document 0001782250-23-000002 Exclusions or Exemptions 506b Accepted Date 2023-12-22 20:46:14 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Lucy Therapeutics, Inc. See All Filings	D	2022-01-06 11:16:52 UTC
Amount To Be Raised $20,000,000 Associated Brokers / Dealers N/A CIK Number 0001782250 Filed Document 0001782250-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-01-06 11:16:52 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Lucy Therapeutics, Inc. See All Filings	D/A	2020-07-22 11:05:41 UTC
Amount To Be Raised $4,509,472 Associated Brokers / Dealers N/A CIK Number 0001782250 Filed Document 0001782250-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-07-22 11:05:41 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Lucy Therapeutics, Inc. See All Filings	D	2019-07-15 11:41:58 UTC
Amount To Be Raised $3,500,000 Associated Brokers / Dealers N/A CIK Number 0001782250 Filed Document 0001782250-19-000003 Exclusions or Exemptions 506b Accepted Date 2019-07-15 11:41:58 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity